Self-assembled nanoparticles of PLGA-conjugated glucosamine as a sustained transdermal drug delivery vehicle

Polymer Journal

Volumn 45, Issue 2, 2013, Pages 202-209

  Marimuthu, Mohana ^a   Bennet, Devasier ^a   Kim, Sanghyo ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

conjugation; glucosamine; nanoparticle skin permeation; PLGA; self assembly; sustained drug delivery

Indexed keywords

CONJUGATION; EX-VIVO; GLUCOSAMINE(GLCN); HUMAN CADAVER SKINS; HYDROPHOBIC POLYMERS; INFLAMMATORY DISEASE; INNER CORE; LAG-TIME; LIPID MEMBRANES; NANOPARTICLE (NPS); OUTER SURFACE; PLGA; POLY(D ,L LACTIC CO GLYCOLIC ACID) (PLGA); PROBE SONICATION; RHEUMATOID ARTHRITIS; SELF ASSEMBLED NANOPARTICLES; SKIN PERMEATION; TRANSDERMAL DELIVERY SYSTEMS; TRANSDERMAL DRUG DELIVERY; TRANSDERMAL PERMEATION;

DISEASES; DRUG DELIVERY; GLUCOSAMINE; GLUCOSE; HYDROPHILICITY; HYDROPHOBICITY; NANOPARTICLES; SELF ASSEMBLY;

COPOLYMERS;

EID: 84873598560     PISSN: 00323896     EISSN: 13490540     Source Type: Journal    
DOI: 10.1038/pj.2012.103     Document Type: Article

References (51)

1. de Jalon, E. G., Blanco-Prieto, M. J., Ygartua, P. & Santoyo, S. PLGA microparticles: possible vehicles for topical drug delivery. Int. J. Pharm. 226, 181-184 (2001).
2. Jenning, V., Gysler, A., Schafer-Korting, M. & Gohla, S. H. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 49, 211-218 (2000).
3. Nohynek, G. J., Lademann, J., Ribaud, C. & Roberts, M. S. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit. Rev. Toxicol. 37, 251-277 (2007).
4. Filipe, P., Silva, J. N., Silva, R., de Castro, J. L. C., Gomes, M. M., Alves, L. C., Santus, R. & Pinheiro, T. Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol. Physiol. 229, 266-275 (2009).
5. Hayden, C. G., Roberts, M. S. & Benson, H. A. Systemic absorption of sunscreen after topical application. Lancet 350, 863-864 (1997).
6. Kuo, T. R., Wu, C. L., Hsu, C. T., Lo, W., Chiang, S. J., Lin, S. J., Dong, C. Y. & Chen, C. C. Chemical enhancer induced changes in the mechanisms of transdermal delivery of zinc oxide nanoparticles. Biomaterials 30, 3002-3008 (2009).
7. Szikszai, Z., Kertesz, Z., Bodnar, E., Major, I., Borbiro, I., Kiss, A. Z. & Hunyadi, J. Nuclear microprobe investigation of the penetration of ultrafine zinc oxide into intact and tape-stripped human skin. Nucl. Instrum. Meth. B 268, 2160-2163 (2010).
8. Tian, J., Wong, K. K., Ho, C. M., Lok, C. N., Yu, W. Y., Che, C. M., Chiu, J. F. & Tam, P. K. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2, 129-136 (2007).
9. Hoffman, A. & Ziv, E. Pharmokinetic considerations of new insulin formulations and routes of administration. Clin. Pharmacokinet. 33, 285-301 (1997).
10. Kari, B. Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin. Diabetes 35, 217-221 (1986).
11. Rendell, M. Advances in diabetes for the millennium, drug therapy of type 2 diabetes. MedGenMed 6, 9-11 (2004).
12. Zhuang, J., Wu, H., Yang, Y. & Cao, Y. C. Controlling colloidal superparticle growth through solvophobic interactions. Angew. Chem. Int. Ed. 47, 2208-2212 (2008).
13. Manoharan, V. N., Elsesser, M. T. & Pine, D. J. Dense packing and symmetry in small clusters of microspheres. Science 301, 483-487 (2003).
14. Brannon-Peppas, L. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int. J. Pharm. 116, 1-9 (1995).
15. Hans, M. L. & Lowman, A. M. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater Sci. 6, 319-327 (2002).
16. Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R. & Rudzinski, W. E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70, 1-20 (2001).
17. Ravi Kumar, M. N. V., Sameti, M., Kneuer, C., Lamprecht, A. & Lehr, C. M. in Encyclopedia of Nanoscience and Nanotechnology (ed. Nalwa, H. S.) Vol. 10, 1-19 (American Scientific Publishers, California, USA, 2003).
18. Luengo, J., Weiss, B., Schneider, M., Ehlers, A., Stracke, F., König, K., Kostka, K. H., Lehr, C. M. & Schaefer, U. F. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol. Physiol. 19, 190-197 (2006).
19. Gu, H. & Roy, K. Topical permeation enhancers efficiently deliver polymer micro and nanoparticles to epidermal Langerhans' cells. J. Drug Del. Sci. Tech. 14, 265-273 (2004).
20. Tekko, I. A., Bonner, M. C. & Williams, A. C. An optimized reverse-phase high performance liquid chromatographic method for evaluating percutaneous absorption of glucosamine hydrochloride. J. Pharm. Biomed. Anal. 41, 385-392 (2006).
21. Kanwischer, M., Kim, S. Y., Kim, J. S., Bian, S., Kwon, K. A. & Kim, D. D. Evaluation of the physicochemical stability and skin permeation of glucosamine sulfate. Drug Dev. Ind. Pharm. 31, 91-97 (2005).
22. Murakami, S. & Aoki, N. Bio-based hydrogels prepared by cross-linking of microbial poly(g-glutamic acid) with various saccharides. Biomacromolecules 7, 2122-2127 (2006).
23. Sun, S. L., Wang, A. Q. & Gao, Y. C. Study on D-glucosamine-zn (II) complexes by IR spectral analysis. Spectrosc. Spect. Anal. 25, 374-376 (2005).
24. Roseman, S. Reflections on glycobiology. J. Biol. Chem. 276, 1527-1542 (2001).
25. Ghosh, S., Blumenthal, H. J., Davidson, E. & Roseman, S. Glucosamine metabolism. V. Enzymatic synthesis of glucosamine 6-phosphate. J. Biol. Chem. 235, 1265-1273 (1960).
26. Coates, J. in Encyclopedia of Analytical Chemistry (ed. Meyers, R. A.) 10815-10837 (John Wiley & Sons Ltd, USA, 2000).
27. Chen, S., Pieper, R., Webster, D. C. & Singh, J. Triblock copolymers: synthesis, characterization, and delivery of a model protein. Int. J. Pharm. 288, 207-218 (2005).
28. Ding, X., Rath, P., Angelo, R., Stringfellow, T., Flanders, E., Dinh, S., Gomez-Orellana, I. & Robinson, J. R. Oral Absorption enhancement of cromolyn sodium through noncovalent complexation. Pharmaceut. Res. 21, 2196-2206 (2004).
29. Barth, H. G. & Mays, J. W. Modern Methods of Polymer Characterization 1-561 (Wiley-Interscience, USA, 1991).
30. Alidedeoglu, A. H., York, A. W., Rosado, D. A., McCormick, C. L. & Morgan, S. E. Bioconjugation of D-glucuronic acid sodium salt to well-defined primary amine-containing homopolymers and block copolymers. J. Polym. Sci. A Polym. Chem. 48, 3052-3061 (2010).
31. Zhou, Z., Ribeiro, A. A. & Raetz, C. R. H. High-resolution NMR spectroscopy of lipid A molecules containing 4-amino-4-deoxy-L-arabinose and phosphoethanolamine substi-tuents. J. Biol. Chem. 275, 13542-13551 (2000).
32. Veerapandian, M. & Yun, K. S. Synthesis of silver nanoclusters and functionalization with glucosamine for glyconanoparticles. Syn. React. Inorg. Metal Org. Chem. 40, 56-64 (2010).
33. Niesz, K. & Morse, D. E. Sonication-accelerated catalytic synthesis of oxide nano-particles. Nano Today 5, 99-105 (2010).
34. Mason, T. J. & Lorimer, J. P. Applied Sonochemistry: Uses of Power Ultrasound in Chemistry and Processing 53-54 (Wiley-VCH Verlag GmbH, Germany, 2002).
35. Han, I. H., Choi, S. U., Nam, D. Y., Park, Y. M., Kang, M. J., Kang, K. H., Kim, Y. M., Bae, G. H., Oh, I. Y., Park, J. H., Ye, J. S., Choi, Y. B., Kim, D. K., Lee, J. W. & Choi, Y. W. Identification and assessment of permeability enhancing vehicles for transdermal delivery of glucosamine hydrochloride. Arch. Pharm. Res. 33, 293-299 (2010).
36. Klimas, M., Brethour, C. & Bucknell, D. International market trends analysis for the functional foods and natural health products industry in the United States, Australia, the United Kingdom and Japan, George Morris Centre. Nutri-Net Canada (2008).
37. Jonathan, O. O. Trans-acidolysis process for the preparation of carbohydrate fatty-acid esters. U.S. Patent 6, 846, 916 Jan 25 (2005).
38. Alvarez-Roman, R., Naik, A., Kalia, Y. N., Guy, R. H. & Fessi, H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm. Res. 21, 1818-1825 (2004).
39. Alvarez-Roman, R., Naik, A., Kalia, Y. N., Guy, R. H. & Fessi, H. Skin penetration and distribution of polymeric nanoparticles. J. Control. Release 99, 53-62 (2004).
40. Zhang, W., Gao, J., Zhu, Q., Zhang, M., Ding, X., Wang, X., Hou, X., Fan, W., Ding, B., Wu, X., Wang, X. & Gao, S. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. Int. J. Pharm. 402, 205-212 (2010).
41. Dinsmore, D., Hsu, M. F., Nikolaides, M. G., Marquez, M., Bausch, A. R. & Weitz, D. A. Colloidosomes: Selectively permeable capsules composed of colloidal particles. Science 298, 1006-1009 (2002).
42. Bera, M. K., Sanyal, M. K., Pal, S., Daillant, J., Datta, A., Kulkarni, G. U., Luzet, D. & Konovalov, O. Reversible buckling in monolayer of gold nanoparticles on water surface. Europhys. Lett. 78, 56003 (2007).
43. Lee, D. & Weitz, D. A. Double emulsion-templated nanoparticle colloidosomes with selective permeability. Adv. Mater. 20, 3498-3503 (2008).
44. Shah, J. C., Sadhale, Y. & Chilukuri, D. M. Cubic phase gels as drug delivery systems. Adv. Drug Deliv. Rev. 47, 229-250 (2001).
45. Lara, M. G., Bentley, M. & Collett, J. H. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int. J. Pharm. 293, 241-250 (2005).
46. Boyd, B. J., Whittaker, D. V., Khoo, S. M. & Davery, G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int. J. Pharm. 309, 218-226 (2006).
47. Cevc, G. & Blume, G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1104, 226-232 (1992).
48. Cevc, G. In Rational for the Production and Dermal Application of Lipid Vesicles (eds Falco, O. B., Korting, H. C. & Maibach, H. I.) 82-90 (Springer-Verlag, Berlin, Germany, 1992).
49. Cevc, G., Schätzlein, A. & Blume, G. Transdermal drug carriers: Basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. Release 36, 3-6 (1995).
50. Cevc, G., Gebauer, D., Stieber, J., Schätzlein, A. & Blume, G. Ultrafexible vesicles, transferosomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1368, 201-215 (1998).
51. Honeywell-Nguyen, P. L., Gooris, G. S. & Bouwstra, J. A. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J. Invest. Dermatol. 123, 902-910 (2004).